Conventional laboratory techniques exhibit impressive sensing performance and still constitute an irreplaceable tool in bioanalytics. Nevertheless, high costs, time consumption, and need for well‐equipped laboratories and skilled personnel make highly desirable to explore novel strategies to carry out biochemical analyses. In this regard, biosensor‐based methods represent a promising approach to keep affordability and rapidity, thus they can inherently pave the way to point of care tests and high‐throughput analysis. Regrettably, most of them suffer from fabrication and biofunctionalization complexity, and poor sensitivities and reliability. Therefore, their adoption as a real alternative to the gold standards is still far from being achieved. However, the massive research on plasmonic nanostructures is revealing their potentialities in sensing field, since they own appealing performances resulting from the plasmon‐related effects and can be easily adapted to a large variety of applications. In this review, a summary of plasmonic biosensors recently devised is reported. Though many nanostructures fit for shared applications, for clarity they are classified into two main categories: i) biosensors whose sensing parameters are plasmon‐related observables (localized, coupled, lattice surface plasmon resonances) and ii) biosensors in which the nanostructure acts as amplifier for an external signal (surface‐enhanced Raman and infrared spectroscopies and plasmon‐enhanced fluorescence).
In the last few decades, plasmonic colorimetric biosensors raised increasing interest in bioanalytics thanks to their cost-effectiveness, responsiveness, and simplicity as compared to conventional laboratory techniques. Potential high-throughput screening and easy-to-use assay procedures make them also suitable for realizing point of care devices. Nevertheless, several challenges such as fabrication complexity, laborious biofunctionalization, and poor sensitivity compromise their technological transfer from research laboratories to industry and, hence, still hamper their adoption on large-scale. However, newly-developing plasmonic colorimetric biosensors boast impressive sensing performance in terms of sensitivity, dynamic range, limit of detection, reliability, and specificity thereby continuously encouraging further researches. In this review, recently reported plasmonic colorimetric biosensors are discussed with a focus on the following categories: (i) on-platform-based (localized surface plasmon resonance, coupled plasmon resonance and surface lattice resonance); (ii) colloid aggregation-based (label-based and label free); (iii) colloid non-aggregation-based (nanozyme, etching-based and growth-based).
Magnetoresistive (MR) biosensors combine distinctive features such as small size, low cost, good sensitivity, and propensity to be arrayed to perform multiplexed analysis. Magnetic nanoparticles (MNPs) are the ideal target for this platform, especially if modified not only to overcome their intrinsic tendency to aggregate and lack of stability but also to realize an interacting surface suitable for biofunctionalization without strongly losing their magnetic response. Here, we describe an MR biosensor in which commercial MNP clusters were coated with gold nanoparticles (AuNPs) and used to detect human IgG in water using an MR biochip that comprises six sensing regions, each one containing five U-shaped spin valve sensors. The isolated AuNPs (satellites) were stuck onto an aggregate of individual iron oxide crystals (core) so that the resulting core@satellite magnetic particles (CSMPs) could be functionalized by the photochemical immobilization technique-an easy procedure that leads to oriented antibodies immobilized upright onto gold. The morphological, optical, hydrodynamic, magnetic, and surface charge properties of CSMPs were compared with those exhibited by the commercial MNP clusters showing that the proposed coating procedure endows the MNP clusters with stability and ductility without being detrimental to magnetic properties. Eventually, the high-performance MR biosensor allowed us to detect human IgG in water with a detection limit of 13 pM (2 ng mL-1). Given its portability, the biosensor described in this paper lends itself to a point-of-care device; moreover, the features of the MR biochip also make it suitable for multiplexed analysis.
The optical response of different configurations of functionalized gold nanoparticles (f-AuNPs) and SARS-CoV-2 virions is simulated in order to explore the behavior of a colloidal solution containing 105–1013 virions/ml. The analysis herein reported is carried out for three concentration regimes: (i) low (≲108 virions/ml), (ii) intermediate (∼109–1010 virions/ml), and (iii) high (≳1011 virions/ml). Given the high binding effectiveness of f-AuNPs to virions, three different configurations are expected to arise: (i) virions completely surrounded by f-AuNPs, (ii) aggregates (dimers or trimers) of virions linked by f-AuNPs, and (iii) single f-AuNP surrounded by virions. It is demonstrated that 20 nm diameter gold nanoparticles functionalized against all three kinds of SARS-CoV-2 proteins (membrane, envelope, and spike) allow one to reach a limit of detection (LOD) of ∼106 virions/ml, whereas the use of only one kind of f-AuNP entails a ten-fold worsening of the LOD. It is also shown that the close proximity (∼5 nm) of the f-AuNP to the virions assumed throughout this analysis is essential to avoid the hook effect, thereby pointing out the importance of realizing an apt functionalization procedure that keeps thin the dielectric layer (e.g., proteins or aptamers) surrounding the gold nanoparticles.
Direct electrostatic self-assembly of cationic AuNPs on glass delivers ultra-uniform, high-density metasurfaces via solvent exchange and fast drying. When particle size is optimal, far-field coupling emerges, boosting plasmonic Q -factors up to ∼15.